RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
D'AVOLIO A
Collezione ASL Città di Torino
Items : 130
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Jun;63(6):107137. doi: 10.1016/j.ijantimicag.2024.107137. Epub 2024 Ma
2024
AOU Città della Salute di Torino
ASL Città di Torino
Calcagno A; D'Avolio A; Di Perri G; Trunfio M; Marinaro L; Bonora S; Avataneo V; Mula J; Antonucci M; Cusato J; Manca A; Palermiti A;
Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116678. doi: 10.1016/j.biopha.2024.116678. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Stroffolini G; Lupia T; De Nicolò A; Antonucci M; Chiara F; Mula J; Palermiti A; Manca A; Boglione L; Cusato J;
Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116686. doi: 10.1016/j.biopha.2024.116686. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano
Antonucci M; Nicolò A; Luxardo N; Imperiale D; Vischia F; De Cori D; Cusato J; D'Avolio A; Palermiti A; Billi M; Valz C; Chiara F; Mula J; Manca A;
Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0023424. doi: 10.1128/aac.00234-24. Epub 2024 May 24.
2024
ASL Città di Torino
Calcagno A; D'Avolio A; Ponzetta L; Marinaro L; Alladio F; Cat Genova E; Quaranta M; Stroffolini G; Gaviraghi A; de Nicolò A; Venuti F;
Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn's Disease. in Biomedicines / Biomedicines. 2024 Jan 30;12(2):320. doi: 10.3390/biomedicines12020320.
2024
AOU Città della Salute di Torino
ASL Città di Torino
Ribaldone DG; Armandi A; Saracco GM; D'Avolio A; Caviglia GP; Vernero M; Manca A; Palermiti A; Antonucci M; Cafasso C; Cusato J;
Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study. in Biomedicines / Biomedicines. 2024 Apr 9;12(4):824. doi: 10.3390/biomedicines12040824.
2024
ASL Città di Torino
Bertani L; Falzone MH; Manca A; D'Avolio A; Costa F; Bottari A; Fornaroli G; Caviglia GP; Saracco GM; Ceccarelli L; Palermiti A; Cusato J; Antonucci M; Ribaldone DG;
Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2024 Apr 26;13(5):518. doi: 10.3390/antiox13050518.
2024
ASL Città di Torino
D'Avolio A; Di Perri G; Lupo C; Rainoldi A; Bonora S; Cuomo S; Trevisan G; Maddalone MG; Tettoni MC; Mula J; Bianco G; Chiara F; Accardo G; Palermiti A; Manca A; Antonucci M; Ferrara M; Cusato J; Mulasso A;
Vitamin D impact in affecting clozapine plasma exposure: A potential contribution of seasonality. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2023 Sep;165:115103. doi: 10.1016/j.biopha.2023.115103. Epub 2023 Jul 4.
2023
ASL Città di Torino
D'Avolio A; Nicolò A; Vivo ED; Cusato J; Maiese D; Antonucci M; Venturello S; Emanuelli G; Cori D; Vischia F; Mula J; Palermiti A; Manca A;
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
Calcagno A; D'Avolio A; Bonora S; Di Perri G; Maiese D; Ferrara M; Antonucci M; Chiara F; De Vivo ED; Costanzo M; Cusato J; Manca A; Mula J; Palermiti A;
COVID-19: A Possible Contribution of the MAPK Pathway. in Biomedicines / Biomedicines. 2023 May 16;11(5):1459. doi: 10.3390/biomedicines11051459.
2023
ASL Città di Torino
Calcagno A; D'Avolio A; De Rosa FG; Di Perri G; Ferrara M; De Vivo ED; Ianniello A; Chiara F; Corcione S; Antonucci M; Trunfio M; Costanzo M; Palermiti A; Mula J; Cusato J; Manca A;
Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Jul 21;12(7):1214. doi: 10.3390/antibiotics12071214.
2023
ASL Città di Torino
Bonora S; Calcagno A; Marchiaro C; D'Avolio A; Cinnirella G; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Stroffolini G; Gaviraghi A; Longo BM; De Nicolò A; Venuti F;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Jan 12;13(2):295. doi: 10.3390/diagnostics13020295.
2023
ASL Città di Torino
Mula J; Bonora S; D'Avolio A; Calcagno A; Di Perri G; Manca A; Palermiti A; Marinaro L; Trunfio M; Cusato J; Avataneo V; Antonucci M;
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano
Calcagno A; Rosa FG; Di Perri G; Chiara F; Antonucci M; De Nicolò A; Allegra S; De Francia S; Palermiti A; Mula J; Manca A; Cusato J; D'Avolio A;
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.
2022
ASL Città di Torino
Smedile A; D'Avolio A; Cantù M; Di Perri G; Saracco GM; Cariti G; Manca A; Mula J; Antonucci M; Ciancio A; Palermiti A; Avataneo V; Troshina G; Caviglia GP; Mornese Pinna S; De Nicolò A; Boglione L; Cusato J;
A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy. in Phytomedicine : international journal of phytotherapy and phytopharmacology / Phytomedicine. 2022 Jul 20;102:154218. doi: 10.1016/j.phymed.2022.154218. Epub 2022 May 28.
2022
ASL Città di Torino
Manca A; Palermiti A; Mula J; De Vivo ED; Zeaiter S; Simiele M; De Nicolò A; Cantù M; Cusato J; D'Avolio A;
Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from "Integriamoci", a Pilot Pharmacokinetic Study. in Molecules (Basel, Switzerland) / Molecules. 2022 Feb 3;27(3):1042. doi: 10.3390/molecules27031042.
2022
ASL Città di Torino
Avataneo V; Palermiti A; De Nicolò A; Cusato J; Giussani G; Calcagno A; D'Avolio A;
A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients. in Irish journal of medical science / Ir J Med Sci. 2022 Feb 19:1-8. doi: 10.1007/s11845-022-02952-9.
2022
ASL Città di Torino
Sanson G; De Nicolò A; Zerbato V; Segat L; Koncan R; Di Bella S; Cusato J; di Masi A; Palermo A; Caironi P; D'Agaro P; Luzzati R; D'Avolio A;
A new UHPLC-MS/MS method for cannabinoids determination in human plasma: A clinical tool for therapeutic drug monitoring. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2022 Dec;156:113899. doi: 10.1016/j.biopha.2022.113899. Epub 2022 Oct 21.
2022
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; De Cori D; Cusato J; Vischia F; Imperiale D; De Filippis G; De Nicolò A; Zeaiter S; Palermiti A; Maiese D; Mula J; Chiara F; Manca A;
Pregnancy and COVID-19: The Possible Contribution of Vitamin D. in Nutrients / Nutrients. 2022 Aug 10;14(16):3275. doi: 10.3390/nu14163275.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Cusato J; De Rosa FG; Benedetto C; D'Avolio A; Antonucci M; Corcione S; Borella F; Carosso AR; Ianniello A; De Vivo ED; Costanzo M; Manca A; Palermiti A; Cosma S;
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Apr 28:1-3. doi: 10.1080/1120009X.2022.2068850.
2022
ASL Città di Torino
Boni S; Antonucci M; Manca A; Nicolò A; Martinelli L; Artioli S; Pacini G; Di Perri G; D'Avolio A;
The importance of Therapeutic Drug Monitoring during pregnancy in a HIV-positive woman taking lifelong antiretroviral therapy in Biochimica Clinica
2022
ASL Città di Torino
Cusato J; D'Avolio A; Di Perri G; Bonora S; Calcagno A; Antonucci M; Marinaro L;
Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy in Journal of preventive medicine and hygiene
2022
ASL Città di Torino
Mastroianni A; Vangeli V; Greco S; Chidichimo L; Urso F; Mauro MV; Bonora S; DE Nicolò A; D'Avolio A;
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study. in Therapie / Therapie. 2021 Sep-Oct;76(5):409-414. doi: 10.1016/j.therap.2020.10.003. Epub 2020 Oct 23.
2021
ASL Città di Torino
AOU Città della Salute di Torino
De Rosa FG; D'Avolio A; Romeo MR; Di Perri G; Stella M; Corgiat Loia R; Corcione S; De Nicolò A; Lupia T; Segala FV; Pensa A;
Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.
2021
ASL Città di Torino
Di Perri G; De Nicolò A; D'Avolio A; Calcagno A; Ianniello A; De Vivo ED; Avataneo V; Cusato J; Mula J; Antonucci M; Manca A; Palermiti A;
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz. in Nutrients / Nutrients. 2021 Oct 12;13(10):3571. doi: 10.3390/nu13103571.
2021
ASL Città di Torino
Calcagno A; Tempestilli M; Cusato J; Vergori A; Piselli P; Antonucci M; Avataneo V; Palermiti A; Notari S; Antinori A; Di Perri G; Agrati C; D'Avolio A;
Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 Nov 27;14(12):1230. doi: 10.3390/ph14121230.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Ribaldone DG; D'Avolio A; Astegiano M; Zanzi F; Cusato J; Ceccarelli L; Costa F; Mangia M; Mula J; Massano A; Dibitetto S; Tomasello C; Caviglia GP; Antonucci M; Bertani L;
An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR). in Trials / Trials. 2021 Nov 23;22(1):831. doi: 10.1186/s13063-021-05752-1.
2021
ASL Città di Torino
Lamorde M; Walimbwa SI; D'Avolio A; Byakika-Kibwika P; Waitt C; Kaboggoza JP;
Pharmacokinetics of bictegravir, emtricitabine and tenofovir alafenamide in a gastrectomized patient with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2021 Nov 12;76(12):3320-3322. doi: 10.1093/jac/dkab319.
2021
ASL Città di Torino
D'Avolio A; Tempestilli M; De Nicolò A; Agrati C; Antinori A; Cicalini S;
Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 14;14(5):462. doi: 10.3390/ph14050462.
2021
ASL Città di Torino
Barco S; Cafaro A; Palermiti A; Bucchioni P; Franceschini P; Cusato J; De Nicolò A; Manca A; De Vivo ED; Russo E; Cecchi F; Pigliasco F; Lillo F; Tripodi G; D'Avolio A; Cangemi G;
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 13;14(5):460. doi: 10.3390/ph14050460.
2021
ASL Città di Torino
Ianniello A; Manca A; De Nicolò A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Piccioni P; D'Avolio A; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Trentalange A; Motta I; Borgogno E;
Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers. in The Journal of steroid biochemistry and molecular biology / J Steroid Biochem Mol Biol. 2021 Jun;210:105854. doi: 10.1016/j.jsbmb.2021.105854. Epub 2021 Feb 22.
2021
AOU San Luigi di Orbassano
ASL Città di Torino
Leoni V; Poli G; Di Perri G; Lembo D; Biasi F; D'Avolio A; Cusato J; Civra A; Boglione L; Caccia C;
Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients. in Scientific reports / Sci Rep. 2021 Jan 11;11(1):443. doi: 10.1038/s41598-020-79574-7.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Romagnoli R; Dell'Olio D; Catalano S; Tandoi F; Canaparo R; Calvo PL; Serpe L; Pizzol A; Antonucci M; D'Avolio A; Pinon M; De Nicolò A;
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino
Di Perri G; D'Avolio A; Bonora S; de Nicolò A; Gervasoni C; Mistrangelo M; Testi R; Cattaneo D; Calcagno A; Dal Conte I;
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):103-109. doi: 10.1007/s40262-020-00916-9.
2021
ASL Città di Torino
Gervasoni C; Borghetti A; Moltó J; Calcagno A; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S;
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):89-102. doi: 10.1007/s40262-020-00913-y.
2021
ASL Città di Torino
van Deun L; Swen JJ; Ettaieb MHT; Yin A; Kerkhofs TMA; van der Straaten RJHM; Corssmit EPM; Gelderblom H; Kerstens MN; Feelders RA; Eekhoff M; Timmers HJLM; D'Avolio A; Cusato J; Guchelaar HJ; Haak HR; Moes DJAR;
Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 Feb 22;14(2):171. doi: 10.3390/ph14020171.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Brusa P; De Luca A; Collino M; Pignata I; Ravetto Enri L; D'Avolio A; Torta R; Baratta F; Simiele M;
Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2021 Dec;87(12):4861-4867. doi: 10.1111/bcp.14895. Epub 2021 Jul 4.
2021
ASL Città di Torino
Scabini S; Montrucchio G; De Nicolò A; Corcione S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A;
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3655-e3664. doi: 10.1210/clinem/dgab290.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Monticone S; Mulatero P; Veglio F; Bertello C; Rabbia F; D'Avolio A; Avataneo V; Rumbolo F; Mengozzi G; Burrello J; Buffolo F; Pecori A;
Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. in American journal of obstetrics and gynecology / Am J Obstet Gynecol. 2021 Apr;224(4):391.e1-391.e7. doi: 10.1016/j.ajog.2020.10.005. Epub 2020 Oct 8
2021
AOU Città della Salute di Torino
ASL Città di Torino
Benedetto C; Di Perri G; Ghisetti V; D'Avolio A; Filippini C; Bovetti M; Carosso M; Borella F; Cosma S; Carosso AR; Cusato J;
Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement. in Frontiers in pharmacology / Front Pharmacol. 2021 May 10;12:668843. doi: 10.3389/fphar.2021.668843. eCollection 2021.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Monticone S; Mulatero P; Rabbia F; Veglio F; D'Avolio A; Avataneo V; Mengozzi G; Priolo G; Losano I; Burrello J; Sconfienza E; Buffolo F;
Risk for SARS-CoV-2 infection in healthcare workers, Turin, Italy in Emerging Infectious Diseases
2021
ASL Città di Torino
Lipani F; Nigra M; D'Avolio A; Bonora S; Di Perri G; Calcagno A; Ghisetti V; Emanuele T; Trunfio M; Faraoni S; Boglione L; Burdino E; Audagnotto S;
Darunavir-based antiretroviral therapy may affect the efficacy of ombitasvir/paritaprevir/ ritonavir and dasabuvir in HCV/ HIV-1 coinfected patients in Clinical Infectious Diseases
2021
ASL Città di Torino
Gervasoni C; Milazzo L; Micheli V; Cattaneo D; D'Avolio A; Sollima S;
A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring. in Frontiers in pharmacology / Front Pharmacol. 2022 Jan 5;12:755184. doi: 10.3389/fphar.2021.755184. eCollection 2021.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Veglio F; D'Avolio A; De Rosa FG; Cusato J; Pappaccogli M; Palermiti A; Rabbia F; Fanelli E; De Nicolò A; Avataneo V;
2021
ASL Città di Torino
AOU Città della Salute di Torino
De Rosa FG; D'Avolio A; Stella M; Di Perri G; Romeo MR; Corgiat Loia R; Pensa A; Segala FV; Lupia T; De Nicolò A; Corcione S;
Low tenofovir plasma exposure in HIV oral pre-exposure prophylaxis recipients with gastrointestinal disorders in Antimicrobial Agents and Chemotherapy
2021
ASL Città di Torino
D'Avolio A; Di Perri G; Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S;
Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritis. in Scientific reports / Sci Rep. 2020 Sep 30;10(1):16178. doi: 10.1038/s41598-020-73183-0.
2020
AOU Città della Salute di Torino
ASL Città di Torino
Ditto MC; Parisi S; Priora M; Sanna S; Peroni CL; Laganà A; D'Avolio A; Fusaro E;
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2020 Oct 1;75(10):2977-2980. doi: 10.1093/jac/dkaa239.
2020
ASL Città di Torino
Ippolito G; Agrati C; D'Avolio A; Nicastri E; Tempestilli M; Caputi P; Avataneo V; Notari S; Lalle E; Capobianchi MR; Castilletti C; Scorzolini L; Ascoli Bartoli T; Marchioni L; Forini O;
25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. in Nutrients / Nutrients. 2020 May 9;12(5):1359. doi: 10.3390/nu12051359.
2020
ASL Città di Torino
Avataneo V; D'Avolio A; Manca A; Cusato J; De Nicolò A; Lucchini R; Keller F; Cantù M;
Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment? in Journal of global antimicrobial resistance / J Glob Antimicrob Resist. 2020 Mar;20:22-27. doi: 10.1016/j.jgar.2019.06.011. Epub 2019 Jun 14.
2020
ASL Città di Torino
De Rosa FG; Stella M; Di Perri G; De Nicolò A; Romeo M; Fatiguso G; Segala FV; Corcione S; D'Avolio A; Pensa A; Loia RC;
Data on the stability of darunavir/cobicistat suspension after tablet manipulation. in Data in brief / Data Brief. 2020 Apr 12;30:105552. doi: 10.1016/j.dib.2020.105552. eCollection 2020 Jun.
2020
ASL Città di Torino
Minghetti P; Tomasello C; Maximova N; Cilurzo F; Musazzi UM; Zanon D; D'Avolio A; Manca A; De Nicolò A;
Impact of imipenem concentration in lung perfusate and tissue biopsy during clinical ex-vivo lung perfusion of high-risk lung donors. in Minerva anestesiologica / Minerva Anestesiol. 2020 Jun;86(6):617-626. doi: 10.23736/S0375-9393.20.13840-9. Epub 2020 Jan 27.
2020
AOU Città della Salute di Torino
ASL Città di Torino
Boffini M; Del Sorbo L; Fanelli V; Costamagna A; Balzano S; Musso T; Scutera S; Cappello P; Mazzeo A; Solidoro P; Baietto L; D'avolio A; Derosa FG; Brazzi L; Mascia L; Rinaldi M; Ranieri VM;
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. in European journal of drug metabolism and pharmacokinetics / Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):405-412. doi: 10.1007/s13318-019-00603-6.
2020
ASL Città di Torino
D'Avolio A; Antonucci M; Manca A; Avataneo V; Allegra S; De Francia S; De Nicolò A; Cusato J;
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2020 Jul 1;75(7):1772-1777. doi: 10.1093/jac/dkaa152.
2020
ASL Città di Torino
de Nicolò A; Avataneo V; Cusato J; Antonucci M; Manca A; Palermiti A; Waitt C; Walimbwa S; Lamorde M; di Perri G; D'Avolio A;
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino
Ferrara M; Ianniello A; De Nicolò A; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;
Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients. in Data in brief / Data Brief. 2020 Dec;33:106445. doi: 10.1016/j.dib.2020.106445. Epub 2020 Oct 23.
2020
ASL Città di Torino
Minghetti P; Clementi E; Tomasello C; Maximova N; Cilurzo F; D'Avolio A; De Nicolò A; Zanon D; Musazzi UM; Manca A;
Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round. in Therapeutic drug monitoring / Ther Drug Monit. 2020 Apr;42(2):165-168. doi: 10.1097/FTD.0000000000000729.
2020
ASL Città di Torino
Cattaneo D; D'Avolio A; Corona A; Veronese A; Agarossi A;
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring. in Therapeutic drug monitoring / Ther Drug Monit. 2020 Apr;42(2):309-314. doi: 10.1097/FTD.0000000000000680.
2020
ASL Città di Torino
Crema F; Marchiselli R; Baruffi K; Franco V; Fattore C; Romigi A; De Giorgis V; Tartara E; Elia M; D'Avolio A; Perucca E;
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation in International Journal of Antimicrobial Agents
2020
ASL Città di Torino
Calcagno A; Di Perri G; Celani L; Bonora S; D'Avolio A; Tettoni M; Lazzaro A; D'Ascenzo F; D'Ettorre G; De Nicolò A; Montrucchio C;
RELATIONSHIP BETWEEN ADALIMUMAB, PHARMACOKINETICS AND VITAMIN D-RELATED MARKERS in Digestive and Liver Disease
2020
ASL Città di Torino
D'Avolio A; Saracco GM; Astegiano M; Mangia M; Cusato J; Ribaldone DG;
Pharmacogenetic markers able to predict lipid-related parameters in a cohort of ritonavir treated patients in Biochimica Clinica
2020
ASL Città di Torino
Palermiti A; Marinaro L; Avataneo V; De Nicolò A; D'Avolio A; Bonora S; Di Perri G; Cusato J; Calcagno A; Antonucci M;
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
AOU San Luigi di Orbassano
ASL Città di Torino
Piga A; Avataneo V; De Nicolò A; Massano D; Pirro E; Longo F; Cusato J; De Francia S; D'Avolio A; Allegra S;
Novel "Matrix-Corrected Calibration" study for the detection of polyunsaturated fatty acids (PUFAs) in plasma and erythrocytes by means of a gas chromatography-mass spectrometry approach optimized to follow up long-term parental patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2019 Nov 30;176:112764. doi: 10.1016/j.jpba.2019.07.012. Epub 2019 Jul 24.
2019
AOU Città della Salute di Torino
ASL Città di Torino
De Francesco A; Mengozzi G; Pazzi M; Aprile S; Massarenti P; Puccinelli MP; Casalini V; Alladio E; Manca A; D'Avolio A;
LC-MS application for therapeutic drug monitoring in alternative matrices. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2019 Mar 20;166:40-51. doi: 10.1016/j.jpba.2018.12.040. Epub 2018 Dec 29.
2019
ASL Città di Torino
Avataneo V; D'Avolio A; Cusato J; Cantù M; De Nicolò A;
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino
Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab. in Cancers / Cancers (Basel). 2019 Jan 21;11(1):125. doi: 10.3390/cancers11010125.
2019
ASL Città di Torino
Grossi F; Ferlazzo G; Boccardo S; Coco S; Di Perri G; Dal Bello MG; Leggieri A; Rijavec E; Cossu I; Mingari MC; Ottonello S; Pietra G; Carrega P; Genova C; Tomasello C; D'Avolio A; Cusato J;
Virological Failure in HIV to Triple Therapy With Dolutegravir-Based Firstline Treatment: Rare but Possible. in Open forum infectious diseases / Open Forum Infect Dis. 2018 Dec 10;6(1):ofy332. doi: 10.1093/ofid/ofy332. eCollection 2019 Jan.
2019
ASL Città di Torino
Zarzalejos JM; Garcia F; D'Avolio A; Chueca N; Pena MJ;
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2019 Aug 5;55(8):441. doi: 10.3390/medicina55080441.
2019
AOU Città della Salute di Torino
ASL Città di Torino
Luzza F; D'Avolio A; Perri GD; Canaparo R; Pellicano R; Riganò D; Simiele M; Agnesod D; Nicolò A; Caviglia GP; Adriani A; Ribaldone DG; Saracco GM; Astegiano M;
Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis. in Neurocritical care / Neurocrit Care. 2019 Aug;31(1):116-124. doi: 10.1007/s12028-018-0657-y.
2019
ASL Città di Torino
Piva S; Di Paolo A; Galeotti L; Ceccherini F; Cordoni F; Signorini L; Togni T; De Nicolò A; Rasulo FA; Fagoni N; Latronico N; D'Avolio A;
Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease. in Mediterranean journal of hematology and infectious diseases / Mediterr J Hematol Infect Dis. 2019 Nov 1;11(1):e2019061. doi: 10.4084/MJHID.2019.061. eCollection 2
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Città di Torino
D'Avolio A; Barbui AM; Guerrasio A; De Gobbi M; Morotti A; Monticone V; Cavallo G; Gned D; Dragani M; Fadda G; Cilloni D; Andreani G;
Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes. in Frontiers in pharmacology / Front Pharmacol. 2019 Jun 25;10:701. doi: 10.3389/fphar.2019.00701. eCollection 2019.
2019
ASL Città di Torino
Brusa P; Collino M; D'Avolio A; De Luca A; Torta R; Ravetto Enri L; Baratta F; Simiele M; Pignata I;
Antiretrovirals concentrations in the olfactory mucosa of hivpositive patients in Topics in Antiviral Medicine
2019
ASL Città di Torino
Calcagno A; De Nicolò A; Trunfio M; Allice T; Imperiale D; Bartoli C; Ghisetti V; Amasio ME; D'Avolio A; Di Perri G; Bonora S;
Development of standard operating protocols for the optimization of cannabis-based formulations for medical purposes in Frontiers in Pharmacology
2019
ASL Città di Torino
Brusa P; D'Avolio A; Collino M; De Luca A; Torta R; Enri LR; Pignata I; Simiele M; Baratta F;
Impact of pharmacogenetic on voriconazole plasma concentration in patients with invasive fungal disease in European Journal of Human Genetics
2019
ASL Città di Torino
D'Avolio A; Di Perri G; Favata F; Arduino A; De Francia S; Fatiguso G; Allegra S;
Virological failure in HIV to triple therapy with dolutegravir-based firstline treatment: Rare but possible in Open Forum Infectious Diseases
2019
ASL Città di Torino
Garcia F; Zarzalejos JM; D'Avolio A; Chueca N; Pena MJ;
Flecainide plasma level modifications during ledipasvir/sofosbuvir coadministration in two patients affected by chronic hepatitis C. in Antiviral therapy / Antivir Ther. 2019;24(7):553-555. doi: 10.3851/IMP3328.
2019
ASL Città di Torino
Boglione L; De Nicolò A; Di Perri G; D'Avolio A;
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples. in Journal of pharmacological and toxicological methods / J Pharmacol Toxicol Methods. 2018 Nov-Dec;94(Pt 2):29-35. doi: 10.1016/j.vascn.2018.08.003. Epub 201
2018
AOU Città della Salute di Torino
ASL Città di Torino
Di Perri G; Veglio F; Mulatero P; Favata F; Allegra S; Fatiguso G; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A;
Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.
2018
AOU Città della Salute di Torino
ASL Città di Torino
D'Avolio A; Cusato J; Pappaccogli M; Berra E; Burrello J; Perlo E; Rabbia F; De Nicolò A; Avataneo V; Di Perri G; Veglio F;
Development and validation of an HPLC-UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV-positive patients. in Biomedical chromatography : BMC / Biomed Chromatogr. 2018 May 4:e4274. doi: 10.1002/bmc.4274.
2018
ASL Città di Torino
Tempestilli M; Ammassari A; D'Avolio A; Cicalini S; Gallo AL; Fazio S; Antinori A; Pucillo LP;
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
AOU San Luigi di Orbassano
ASL Città di Torino
Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A;
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22
2018
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. in Pharmacogenomics / Pharmacogenomics. 2018 Jun 1;19(8):701-707. doi: 10.2217/pgs-2018-0009. Epub 2018 May 23.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Pinna SM; Carcieri C; Guido F; Cariti G; Di Perri G; D'Avolio A;
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Pharmacogenetic of voriconazole antifungal agent in pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2018 Jul 1;19(11):913-925. doi: 10.2217/pgs-2017-0173. Epub 2018 Jun 19.
2018
ASL Città di Torino
D'Avolio A; Perri GD; Avataneo V; Nicolò A; Cusato J; Francia S; Pirro E; Carcieri C; Allegra S; Fatiguso G;
Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.
2018
ASL Città di Torino
D'Avolio A; Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; Carcieri C;
Precision medicine for HIV: where are we? in Pharmacogenomics / Pharmacogenomics. 2018 Jan;19(2):145-165. doi: 10.2217/pgs-2017-0123. Epub 2017 Dec 5.
2018
ASL Città di Torino
D'Avolio A; Calcagno A; Nicolò A; Allegra S; Cusato J;
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
Cusato J; Carcieri C; De Nicolò A; Di Perri G; D'Avolio A; Allegra S; Fatiguso G; Pirro E; Favata F; De Francia S;
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Jan;28(1):17-22. doi: 10.1097/FPC.0000000000000315.
2018
ASL Città di Torino
Allegra S; Cusato J; De Francia S; Longo F; Pirro E; Massano D; Piga A; D'Avolio A;
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Feb 1;73(2):546-548. doi: 10.1093/jac/dkx385.
2018
ASL Città di Torino
Motta I; Trunfio M; Calcagno A; Pirriatore V; Scabini S; Palazzo A; Audagnotto S; Fatiguso G; Liberini V; Bellò M; D'Avolio A; Di Perri G; Bonora S;
Clinical relevance of deferasirox trough levels in ?-thalassemia patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2018 Feb;45(2):213-216. doi: 10.1111/1440-1681.12879. Epub 2017 Dec 4.
2018
AOU San Luigi di Orbassano
ASL Città di Torino
D'Avolio A; Cusato J; Pirro E; Piccione F; Longo F; De Francia S; Massano D; Allegra S; Piga A;
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino
Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. in Archives of virology / Arch Virol. 2018 Apr;163(4):961-967. doi: 10.1007/s00705-017-3684-7. Epub 2018 Jan 9.
2018
ASL Città di Torino
Boglione L; Cusato J; Pinna SM; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Vitamin D plasma level is able to affect nivolumab drug exposure in a cohort of patients with non small cell lung cancer in Biochimica Clinica
2018
ASL Città di Torino
D'Avolio A; Di Perri G; Grossi F; Ferlazzo G; Mingari MC; Cossu I; Pietra G; Ottonello S; Tomasello C; Genova C; Carrega P; Cusato J;
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients in Pharmacogenetics and Genomics
2018
ASL Città di Torino
D'Avolio A; Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S;
Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B. in Antiviral therapy / Antivir Ther. 2018;23(4):373-377. doi: 10.3851/IMP3207.
2018
ASL Città di Torino
De Nicolò A; Boglione L; Cusato J; Fatiguso G; Favata F; Allegra S; Cariti G; Di Perri G; D'Avolio A;
The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Sep;44(9):965-968. doi: 10.1111/1440-1681.12786.
2017
ASL Città di Torino
El Desoky ES; Abdelhafez AT; Cusato J; Kamel SI; Hussein AM; De Nicolo A; Di Perri G; D'Avolio A;
Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Sep;53:195-198. doi: 10.1016/j.meegid.2017.05.026. Epub 2017 Jun 1.
2017
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Oct 25;145:718-724. doi: 10.1016/j.jpba.2017.07.040. Epub 2017 Aug 5.
2017
ASL Città di Torino
Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A;
Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3. in European journal of public health / Eur J Public Health. 2017 Oct 1;27(5):938-941. doi: 10.1093/eurpub/ckx025.
2017
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Influence of ABCB11 and HNF4? genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.
2017
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient. in Journal of clinical pharmacy and therapeutics / J Clin Pharm Ther. 2017 Oct;42(5):621-623. doi: 10.1111/jcpt.12546. Epub 2017 May 4.
2017
ASL Città di Torino
Taibi C; Tempestilli M; D'Avolio A; Garbuglia AR; De Nicolò A; Montalbano M; D'Offizi G;
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study. in Journal of viral hepatitis / J Viral Hepat. 2017 Oct;24(10):850-857. doi: 10.1111/jvh.12711. Epub 2017 Apr 25.
2017
ASL Città di Torino
Boglione L; Mornese Pinna S; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; De Nicolò A; Di Perri G; Cusato J; Pirro E; Carcieri C; Favata F; De Francia S; Fatiguso G; Allegra S;
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
AOU San Luigi di Orbassano
ASL Città di Torino
Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
D'Avolio A; Cusato J; Di Perri G; De Nicolò A; De Francia S; Carcieri C; Pirro E; Favata F; Fatiguso G; Allegra S;
A rapid and robust UHPLC-DAD method for the quantification of amphotericin B in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 May 10;138:142-145. doi: 10.1016/j.jpba.2017.01.048. Epub 2017 Feb 8.
2017
ASL Città di Torino
Barco S; Zunino A; D'Avolio A; Barbagallo L; Maffia A; Tripodi G; Castagnola E; Cangemi G;
Deferasirox pharmacokinetic evaluation in ?-thalassaemia paediatric patients. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 May;69(5):525-528. doi: 10.1111/jphp.12559. Epub 2016 May 27.
2017
AOU San Luigi di Orbassano
ASL Città di Torino
D'Avolio A; Piga A; Massano D; Pirro E; De Francia S; Cusato J; Allegra S;
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):607-611. doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Imbornone R; Cardellino CS; Ghisetti V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
First UHPLC-MS/MS method coupled with automated online SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients. in Journal of mass spectrometry : JMS / J Mass Spectrom. 2017 Mar;52(3):187-195. doi: 10.1002/jms.3909.
2017
AOU Città della Salute di Torino
ASL Città di Torino
Tandoi F; Romagnoli R; Nonnato A; Calvo PL; Pisciotta C; De Nicolò A; Pinon M; Pensi D; Di Perri G; D'Avolio A;
Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2017 Jun;49(6):784-785. doi: 10.1016/j.ijantimicag.2017.04.002. Epub 2017 A
2017
ASL Città di Torino
AOU Città della Salute di Torino
Di Perri G; Ranieri MV; Urbino R; Allegra S; Fanelli V; D'Avolio A; Corcione S; De Rosa FG;
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. in Pharmacogenomics / Pharmacogenomics. 2017 Jun;18(9):865-880. doi: 10.2217/pgs-2017-0176. Epub 2017 Jun 8.
2017
ASL Città di Torino
Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A;
Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Jun;49(6):705-708. doi: 10.1016/j.dld.2017.01.144. Epub 2017 Jan 17.
2017
ASL Città di Torino
Boglione L; De Nicolò A; Mornese Pinna S; Cusato J; Favata F; Ariaudo A; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect. in Bioanalysis / Bioanalysis. 2017 Jul;9(14):1093-1105. doi: 10.4155/bio-2017-0059. Epub 2017 Jul 24.
2017
ASL Città di Torino
De Nicolò A; Cantù M; D'Avolio A;
Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Jul;51:167-172. doi: 10.1016/j.meegid.2017.03.014. Epub 2017 Mar 16.
2017
ASL Città di Torino
Boglione L; Cardellino CS; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Jan;72(1):319-321. doi: 10.1093/jac/dkw361. Epub 2016 Sep 2.
2017
ASL Città di Torino
AOU Città della Salute di Torino
D'Avolio A; Di Perri G; Stella M; Malvasio V; Baietto L; Corcione S; De Rosa FG;
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.
2017
ASL Città di Torino
Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. in Infection / Infection. 2017 Feb;45(1):103-106. doi: 10.1007/s15010-016-0962-3. Epub 2016 Nov 16.
2017
ASL Città di Torino
Boglione L; Pinna SM; Cardellino CS; De Nicolò A; Cusato J; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Aug 5;142:279-285. doi: 10.1016/j.jpba.2017.05.018. Epub 2017 May 13.
2017
AOU Città della Salute di Torino
ASL Città di Torino
D'Avolio A; Di Perri G; Veglio F; Mulatero P; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; De Nicolò A; Avataneo V;
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2017 Apr;18(6):539-554. doi: 10.2217/pgs-2016-0176. Epub 2017 Mar 27.
2017
AOU San Luigi di Orbassano
ASL Città di Torino
Piga A; Longo F; Massano D; Arduino A; Cusato J; De Francia S; Allegra S; D'Avolio A;
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2017 Apr;79(4):767-773. doi: 10.1007/s00280-017-3271-3. Epub 2017 Mar 13
2017
AOU San Luigi di Orbassano
ASL Città di Torino
Petrini M; Danesi R; Arrigoni E; Grassi S; Ciabatti E; Fontanelli G; Guerrini F; Cervetti G; D'Avolio A; Fava C; Baratè C; Di Paolo A; Polillo M; Laurino M; Domingo D; Galeotti L; Ceccherini F; Cornolti F; Saglio G; Galimberti S;
Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs. in Clinical pharmacokinetics / Clin Pharmacokinet. 2017 Apr;56(4):355-369. doi: 10.1007/s40262-016-0456-6.
2017
ASL Città di Torino
Calcagno A; Cusato J; D'Avolio A; Bonora S;
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump. in International journal of pharmaceutical compounding / Int J Pharm Compd. 2016 Jul-Aug;20(4):343-346.
2016
ASL Città di Torino
AOU Città della Salute di Torino
De Perri G; De Nicolò A; Fulcheri C; Baietto L; Veglio F; Rabbia F; Leggieri A; Tomasello C; D'Avolio A;
UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.
2016
ASL Città di Torino
Di Perri G; Tomasello C; Pensi D; Cusato J; Boglione L; Bonifacio G; De Nicolò A; D'Avolio A;
Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino
Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A;
In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing Meropenem. in Hospital pharmacy / Hosp Pharm. 2015 Apr;50(4):296-303. doi: 10.1310/hpj5004-296. Epub 2015 Apr 8.
2015
ASL Città di Torino
D'Avolio A; Di Perri G; Cavalli R; Leggieri A; Tomasello C;
2011
ASL Città di Torino
Calcagno A; Bonora S; Simiele M; Rostagno R; Tettoni MC; Bonasso M; Romito A; Imperiale D; D'Avolio A; Di Perri G;
Tenofovir and emtricitabine CSF-to-plasma ratios correlate to the extent of blood-brain-barrier damage in Infection
2011
ASL Città di Torino
Calcagno A; Bonora S; Simiele M; Audagnotto S; Siccardi M; De Requena DG; Romito A; Imperiale D; D'Avolio A; Di Perri G;
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism in Pharmacogenetics and Genomics
2010
ASL Città di Torino
Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan W-S; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;